Skip to main content

Table 4 Five-year overall survival

From: Five-year disease-free survival among stage II-IV breast cancer patients receiving FAC and AC chemotherapy in phase II clinical trials of Panagen

 

Chemotherapy + Placebo

Chemotherapy + Panagen

[38]

[24]

[39]

Patients

Survived patients

%

Patients

Survived patients

%

Survival, %

Survival, %

Survival, %

I

      

100.0

92.1

 

II

4

4

100

19

17

89

89.0

81.8

 

III

8

4

50

25

21

84

80.8

58.0

 

IV

3

0

0

7

2

29

   

Total

15

8

53

51

40

78

  

40–70